litlas
Log inCreate account

Thierry Naas

Active 1991–2025

178
Papers
23,913
Citations
79
h-index
170
i10-index

Citations

Citations per year for Thierry Naas1990: 1 citations1992: 7 citations1993: 4 citations1994: 12 citations1995: 21 citations1996: 18 citations1997: 36 citations1998: 54 citations1999: 61 citations2000: 86 citations2001: 120 citations2002: 133 citations2003: 121 citations2004: 117 citations2005: 126 citations2006: 138 citations2007: 127 citations2008: 145 citations2009: 177 citations2010: 236 citations2011: 264 citations2012: 287 citations2013: 286 citations2014: 257 citations2015: 246 citations2016: 236 citations2017: 209 citations2018: 142 citations2019: 697 citations2020: 786 citations2021: 789 citations2022: 731 citations2023: 513 citations2024: 866 citations2025: 428 citations2026: 11 citations1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,574 citing papers, 17.4% of this breakdownFrance: 706 citing papers, 7.8% of this breakdownChina: 618 citing papers, 6.8% of this breakdownUnited Kingdom: 562 citing papers, 6.2% of this breakdownItaly: 431 citing papers, 4.8% of this breakdownSpain: 378 citing papers, 4.2% of this breakdownGermany: 333 citing papers, 3.7% of this breakdownIndia: 252 citing papers, 2.8% of this breakdownAustralia: 238 citing papers, 2.6% of this breakdownCanada: 218 citing papers, 2.4% of this breakdownSwitzerland: 204 citing papers, 2.3% of this breakdownJapan: 186 citing papers, 2.1% of this breakdown
0%17.4%Other 36.9%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology73.3%
  • Agricultural and Biological Sciences8.6%
  • Medicine7.9%
  • Immunology and Microbiology4.9%
  • Environmental Science2.8%
  • Engineering0.8%
  • Other1.7%

Topics

  • Antibiotic Resistance in Bacteria24.3%
  • Antibiotics Pharmacokinetics and Efficacy6.6%
  • Antibiotic Use and Resistance5%
  • Pharmaceutical and Antibiotic Environmental Impacts4.9%
  • Bacterial Identification and Susceptibility Testing4.7%
  • Bacterial biofilms and quorum sensing3.6%
  • Other50.9%

Coauthors

All papers

Open in search
  1. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial

    Authors: Matteo Bassetti, Roger Echols, Yuko Matsunaga, Mari Ariyasu, Yohei Doi, Ricard Ferrer, Thomas P. Lodise, Thierry Naas, Yoshihito Niki, David L. Paterson, Simon Portsmouth, Julián Torre‐Cisneros, Kiichiro Toyoizumi, Richard G. Wunderink, Tsutae Den Nagata - The Lancet Infectious Diseases 2020 cited by 792

  2. Beta-lactamase database (BLDB) – structure and function

    Authors: Thierry Naas, Saoussen Oueslati, Rémy A. Bonnin, Maria Laura Dabos, Agustín Jacinto Zavala, Laurent Dortet, Pascal Retailleau, Bogdan I. Iorga - Journal of Enzyme Inhibition and Medicinal Chemistry 2017 cited by 686

  3. Global Spread of Carbapenemase-producingEnterobacteriaceae

    Authors: Patrice Nordmann, Thierry Naas, Laurent Poirel - Emerging infectious diseases 2011 cited by 2,326

  4. Antimicrobial Peptides: A Potent Alternative to Antibiotics

    Authors: Mariam Rima, Mohamad Rima, Ziad Fajloun, Jean‐Marc Sabatier, Burkhard Bechinger, Thierry Naas - Antibiotics 2021 cited by 336

  5. The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee

    Authors: M.J. Ellington, Oskar Ekelund, Frank M. Aarestrup, Rafael Cantón, Michel Doumith, Christian G. Giske, H. Grundman, Henrik Hasman, Matthew T. G. Holden, Katie L. Hopkins, Jonathan R. Iredell, Gunnar Kahlmeter, Claudio U. Köser, Alasdair MacGowan, Dik Mevius, M. R. Mulvey, Thierry Naas, Tim Peto, Jean‐Marc Rolain, Ørjan Samuelsen, Neil Woodford - Clinical Microbiology and Infection 2016 cited by 579

  6. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

    Authors: Patrice Nordmann, Gaëlle Cuzon, Thierry Naas - The Lancet Infectious Diseases 2009 cited by 1,582

  7. Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group

    Authors: Antonio Oliver, Estrella Rojo‐Molinero, Jorge Arca-Suárez, Yeşim Besli, Pierre Bogaerts, Rafael Cantón, Cansu Çimen, P Croughs, Olivier Denis, Christian G. Giske, Tíscar Graells, Te‐Din Huang, Bogdan I. Iorga, Onur Karatuna, Béla Kocsis, Andreas Kronenberg, Carla López-Causapé, Surbhi Malhotra‐Kumar, Luis Martínez‐Martínez, Annarita Mazzariol, Sylvain Meyer, Thierry Naas, Daan W. Notermans, Jesús Oteo, Torunn Pedersen, Mateja Pirš, Patrícia Poeta, Laurent Poirel, Spyros Pournaras, Arnfinn Sundsfjord, Dóra Szabó, Arjana Tambić-Andrašević, Rossitza Vatcheva-Dobrevska, Astra Vitkauskienė, Katy Jeannot - Clinical Microbiology and Infection 2023 cited by 94

  8. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

    Authors: Rafael Cantón, Murat Akova, Yehuda Carmeli, Christian G. Giske, Y. Glupczynski, Marek Gniadkowski, David M. Livermore, Vivì Miriagou, Thierry Naas, Gian María Rossolini, Ørjan Samuelsen, Harald Seifert, Neil Woodford, Patrice Nordmann - Clinical Microbiology and Infection 2012 cited by 881

  9. Diversity, Epidemiology, and Genetics of Class D β-Lactamases

    Authors: Laurent Poirel, Thierry Naas, Patrice Nordmann - Antimicrobial Agents and Chemotherapy 2009 cited by 614

  10. Worldwide Dissemination of theblaOXA-23Carbapenemase Gene ofAcinetobacter baumannii1

    Authors: Pauline Mugnier, Laurent Poirel, Thierry Naas, Patrice Nordmann - Emerging infectious diseases 2009 cited by 415

  11. Escherichia coli: an old friend with new tidings

    Authors: Jordi Vilà, Emma Sáez-López, James R. Johnson, Ute Römling, Ulrich Dobrindt, Rafael Cantón, Christian G. Giske, Thierry Naas, Alessandra Carattoli, Margarita Martínez-Medina, Jordi Bosch, Pilar Retamar, Jesús Rodríguez‐Baño, Fernando Baquero, Sara M. Soto - FEMS Microbiology Reviews 2016 cited by 334

  12. Clinical bacteriology in low-resource settings: today's solutions

    Authors: Sien Ombelet, Jean‐Baptiste Ronat, Timothy R. Walsh, Cédric P. Yansouni, Janneke Cox, Erika Vlieghe, Delphine Martiny, Makeda Semret, Olivier Vandenberg, Jan Jacobs, Octavie Lunguya, Marie-France Phoba, Palpouguini Lompo, Thong Phe, Samuel Kariuki, Paul N. Newton, David A. B. Dance, Claude Mambo Muvunyi, Sayda El Safi, Barbara Barbé, Dadi Falay, Dissou Affolabi, Maurice PAGE, Céline Langendorf, Y. Gille, Tjalling Leenstra, John Stelling, Thierry Naas, Thomas Kesteman, Daniel Seifu, Elisabeth Delarocque‐Astagneau, Constance Schultsz, Heidi Schütt‐Gerowitt, Joanne Letchford, Heiman Wertheim, Gunnar Kahlmeter, Awa Kane - The Lancet Infectious Diseases 2018 cited by 200

  13. Genetics of Acquired Antibiotic Resistance Genes in Proteus spp.

    Authors: Delphine Girlich, Rémy A. Bonnin, Laurent Dortet, Thierry Naas - Frontiers in Microbiology 2020 cited by 182

  14. Functional Characterization of Tn 4401 , a Tn 3 -Based Transposon Involved in bla KPC Gene Mobilization

    Authors: Gaëlle Cuzon, Thierry Naas, Patrice Nordmann - Antimicrobial Agents and Chemotherapy 2011 cited by 218

  15. High Frequency Retrotransposition in Cultured Mammalian Cells

    Authors: John V. Moran, Susan E. Holmes, Thierry Naas, Ralph J. DeBerardinis, Jef D. Boeke, Haig H. Kazazian - Cell 1996 cited by 1,043

  16. A multiplex lateral flow immunoassay for the rapid identification of NDM-, KPC-, IMP- and VIM-type and OXA-48-like carbapenemase-producing Enterobacteriaceae

    Authors: Hervé Boutal, Anaïs Vogel, Sandrine Bernabeu, Karine Devilliers, Elodie Creton, Garence Cotellon, Marc Plaisance, Saoussen Oueslati, Laurent Dortet, Agnès B. Jousset, Stéphanie Simon, Thierry Naas, Hervé Volland - Journal of Antimicrobial Chemotherapy 2017 cited by 222

  17. Comparison of disk diffusion, MIC test strip and broth microdilution methods for cefiderocol susceptibility testing on carbapenem-resistant enterobacterales

    Authors: Rémy A. Bonnin, Cécile Emeraud, Agnès B. Jousset, Thierry Naas, Laurent Dortet - Clinical Microbiology and Infection 2022 cited by 73

  18. Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales

    Authors: Keith S. Kaye, Thierry Naas, Jason M. Pogue, Gian María Rossolini - Infectious Diseases and Therapy 2023 cited by 57

  19. Genetic Structures at the Origin of Acquisition of the β-Lactamase bla KPC Gene

    Authors: Thierry Naas, Gaëlle Cuzon, María Virginia Villegas, Marie-Frédérique Lartigue, John P. Quinn, Patrice Nordmann - Antimicrobial Agents and Chemotherapy 2008 cited by 534

  20. All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies

    Authors: Thomas P. Lodise, Matteo Bassetti, Ricard Ferrer, Thierry Naas, Yoshihito Niki, David L. Paterson, Markus Zeitlinger, Roger Echols - Expert Review of Anti-infective Therapy 2021 cited by 58

  21. In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations

    Authors: Anne Santerre Henriksen, Katy Jeannot, Antonio Oliver, John D. Perry, Mathias W. Pletz, Stefania Stefani, Ian Morrissey, Christopher Longshaw, ARTEMIS Study Investigators, Birgit Willinger, David Leyssene, C. Cattoën, Corentine Alauzet, Pierre Boyer, Véronique Dubois, Katy Jeannot, Stéphane Corvec, Jean‐Philippe Lavigne, Thomas Guillard, Audrey Merens Gontier, Thierry Naas, Holger Rohde, Stefan Ziesing, Can Imirzalioglu, Klaus‐Peter Hunfeld, Jette Jung, Sören Gatermann, Mathias W. Pletz, Gabriele Bianco, Anna Giammanco, Davide Carcione, Giammarco Raponi, Caterina Matinato, Enea Gino Di Domenico, Paolo Gaibani, Anna Marchese, Fabio Arena, Claudia Niccolai, Stefania Stefani, Cristina Pitart, José Luís González Barrios, Emilia Cercenado, Germán Bou, Alicia Beteta López, Rafael Cantón, Jose Lopez Hontangas, Irene Gracia-Ahufinger, Antonio Oliver, Lorena López‐Cerero, Nieves Larrosa, David W. Wareham, John D. Perry, Anna Casey, Jasvir Nahl, Daniel Hughes, Michael J. Coyne, Michelle M. Lister, Marie Attwood - Microbiology Spectrum 2024 cited by 32

  22. Genetic Diversity, Biochemical Properties, and Detection Methods of Minor Carbapenemases in Enterobacterales

    Authors: Rémy A. Bonnin, Agnès B. Jousset, Cécile Emeraud, Saoussen Oueslati, Laurent Dortet, Thierry Naas - Frontiers in Medicine 2021 cited by 92

  23. The Revolution of Lateral Flow Assay in the Field of AMR Detection

    Authors: Hervé Boutal, Christian Moguet, Lilas Pommiès, Stéphanie Simon, Thierry Naas, Hervé Volland - Diagnostics 2022 cited by 40

  24. Biochemical Characterization of the Naturally Occurring Oxacillinase OXA-50 ofPseudomonas aeruginosa

    Authors: Delphine Girlich, Thierry Naas, Patrice Nordmann - Antimicrobial Agents and Chemotherapy 2004 cited by 203